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Available online 27 December 2014AbstractIntroduction: Nephron-sparing surgery (NSS) has become the standard of care for the surgical management of small and clinically localized
renal cell carcinoma (RCC). The conservative management of those RCCs is increasing over time. Aim of this study was to report a snap-
shot of the clinical, perioperative and oncological results after NSS for RCC in Italy.
Material and methods: We evaluated all patients who underwent conservative surgical treatment for renal tumours between January 2009
and December 2012 at 19 urological Italian Centers (RECORd project). Perioperative, radiological and histopathological data were re-
corded. Surgical eras (2009 vs 2012 and year periods 2009e2010 vs 2011e2012) were compared.
Results: Globally, 983 patients were evaluated. More recently, patients undergoing NSS were found to be significantly younger (p ¼ 0.05)
than those surgically treated in the first study period, with a significantly higher rate of NSS with relative and imperative indication
(p < 0.001). More recently, a higher percentage of procedures for cT1b or cT2 renal tumours was observed (p ¼ 0.02). Utilization rate
of open partial nephrectomy (OPN) constantly decreased during years, laparoscopic partial nephrectomy (LPN) remained almost constant
while robot-assisted partial nephrectomy (RAPN) increased. The rate of clampless NSS constantly increased over time. The use of at least
one haemostatic agent has been significantly more adopted in the most recent surgical era (p < 0.001).
Conclusions: The utilization rate of NSS in Italy is increasing, even in elective and more complex cases. RAPN has been progressively
adopted, as well as the intraoperative utilization of haemostatic agents and the rate of clampless procedures.
 2014 Elsevier Ltd. All rights reserved.
Keywords: Renal cell carcinoma; Partial nephrectomy; Nephron-sparing surgery; Minimally invasive techniques; Outcomesthor. Department of Urology, University of Bologna, S. Orsola-Malpighi Hospital, Palagi 9, 40134, Bologna, Italy. Tel.: þ39
9 0516362747.
chiavina@yahoo.it (R. Schiavina).
16/j.ejso.2014.12.001
sevier Ltd. All rights reserved.
347R. Schiavina et al. / EJSO 41 (2015) 346e352Introduction affect kidney function in the future) and absolute (bilateralBased on the GLOBOCAN estimates, over 143.300 new
renal cell carcinoma (RCC) between both genders have
been diagnosed in 2012, accounting for approximately
74.900 deaths in the developed countries.1 The increased
diagnosis of RCC led to a concurrent rise in the utilization
of surgical procedures and to an augmented interest in the
various techniques of nephron-sparing surgery (NSS) over
radical nephrectomy (RN). NSS demonstrated to offer can-
cer specific free-survival rates comparable to radical ne-
phrectomy (RN), but with lower risk of surgically
induced chronic kidney disease (CKD), cardiovascular
events and metabolic sequelae.2,3 For this reason, European
guidelines has recently accepted as standard of care NSS
for the treatment of 4 cm renal tumours and recommen-
ded a conservative surgery for 4e7 cm (cT1b) renal masses
whenever technically feasible.4 However, the surgical treat-
ment of renal tumours still represents an area of active clin-
ical research and controversies still exist, which includes
the therapeutic strategy (NSS, RN), the technique to
perform NSS (partial nephrectomy, tumour enucleation),
the approach for NSS (open, laparoscopic, robotic) and
whether or not to clamp the renal pedicle during NSS.
Aim of the present study was to report data of a large cohort
of patients undergoing NSS for renal tumours between
January 2009 and December 2012 among Italian Centres,
and to offer a “real-life” description of the clinical, periop-
erative and pathological results after NSS for renal tumours
together with a comparison among the different surgical
periods.
Material and methods
The Italian Registry of Conservative Renal Surgery (RE-
CORd Project) is a 4-Year prospective observational multi-
center study promoted by the Leading Urological No profit
foundation Advanced research (LUNA) of the Societa Ital-
iana di Urologia (SIU). The RECORd project includes all
patients who underwent conservative surgical treatment
for radiologically diagnosed renal cell carcinoma (RCC)
between January 2009 and December 2012 at 19 urological
Italian Centres, upon the approval of the study protocol by
the local ethical committee and patients’ acceptance of the
written informed consent. Overall, information about 1055
patients were collected. An online database was generated
and it comprises 5 main folders: 1) Anthropometric and
Preoperative data; 2) Imaging, Indications and Comorbid-
ities; 3) Intraoperative Data; 4) Postoperative Data; 5) His-
topathological Analysis. All data were centrally recorded
on a data server. All preoperative anthropometric character-
istics were collected (gender, age, BMI). Surgical indica-
tions were defined as elective (localized unilateral RCC
with healthy contralateral kidney), relative (localized uni-
lateral RCC with the coexistence of comorbidities such as
diabetes, hypertension or lithiasis that could potentiallytumours, multiple tumours, moderate to severe CKD or in
case of neoplasia involving an anatomically or functionally
solitary kidney). Performance status was assigned accord-
ing to the ECOG criteria.5 Mode of presentation of the
tumour was defined according to the Patard classification.6
In all patients clinical workup included at least abdominal
computed tomography (CT) scans and chest X-rays. Chest
and brain CT scans were obtained only when indicated by
signs and symptoms. Tumours were classified according to
their location on the longitudinal plane (upper pole, middle
part, and lower pole) and on the transverse plane (anterior
surface, posterior surface, lateral margin, medial margin,
peri-hilar) of the kidney. According to the degree of depth
into the kidney, each tumour was also classified into three
growth pattern categories: 1) prevalently (50%) exo-
phytic, 2) prevalently endophytic (<50% exophytic), and
3) entirely endophytic. Analysing full dataset of 1055
cases, centres were divided in low- and high-volume ac-
cording to the threshold of 50 interventions of NSS per
year. All intraoperative data including surgical approach
and technique, the decision whether or not to clamp the
renal vessels, type of ischaemia, ischaemia time, intraoper-
ative blood loss and operative time were recorded. The
minimally invasive (video laparoscopic or robot assisted)
and open approaches as well as the surgical technique, per-
formed in the form of standard PN and simple enucleation
(SE), were adopted according to the centres’ and surgeons’
preference. Standard PN has been defined as the excision of
the tumour and of a minimal margin of healthy peritumoral
renal parenchyma.7 SE has been defined as the blunt
tumour excision without removing a visible rim of paren-
chymal tissue around the pseudocapsule.7 All surgical spec-
imens were processed according to standard pathological
procedures at each institution by experienced uropatholo-
gists. For surgical margins evaluation the specimens were
fixed in 10% buffered formalin, and grossly analysed.
The size, the colour, the gross aspect (solid to cystic)
were recorded and the surgical margin was marked with
ink. After tumour dissection, samplings were performed
in order to obtain tissue blocks where tumour, renal paren-
chyma, and surgical edges were comprised and further
blocks where tumour, renal capsule, and peritumoral fat
were enclosed. The margin was considered positive when
tumour tissue was marked with ink. The margin was
considered negative when no-neoplastic renal tissue was
observed between tumour tissue and the line of ink. Tu-
mours were pathologically staged according to the Amer-
ican Joint Committee on Cancer TNM classification.8Statistical analysisContinuous variables were reported as mean (SD) or as
median and IQR, as appropriate. The Student t test and the
ManneWhitney U test were used to compare continuous
variables and the Pearson’s chi square test was used to
348 R. Schiavina et al. / EJSO 41 (2015) 346e352compare categorical variables. Surgical eras (2009 vs 2012
and year periods 2009e2010 vs 2011e2012) were
compared regarding clinical and surgical variables. Statisti-
cal significance in this study was set as p  0.05. All re-
ported p values are two-sided. Analyses were performed
with SPSS version 20.0 (SPSS Inc, Chicago, IL, USA).
Results
A total of 1055 patients from 19 Italian Centers were
included in the study. After exclusion of 72 patients with
incomplete perioperative data, the remaining 983 patients
were evaluated for the final analyses. Overall, 64.8% of pa-
tients were male, and the majority of them were fit and fully
active at the time of surgery (ECOG performance
status ¼ 0: 69.1%). The most relevant clinical and demo-
graphic results, together with a comparison among the
different surgical eras are reported in Table 1. In the most
recent years, patients undergoing NSS were found to be
significantly younger (p ¼ 0.05), with a significantly higher
percentage of ECOG 0 (p ¼ 0.002) and asymptomatic pre-
sentation (p < 0.0001) than those surgically treated in the
first study period. In all the centres, most of the PN were
performed with elective indication, even if a significantly
higher rate of NSS with relative and imperative indication
was observed in the most recent years (p < 0.001, Table
1). Notably, patients undergoing partial nephrectomy were
diagnosed with slightly larger renal tumours over time
(p ¼ 0.04) and, therefore, a higher percentage of proceduresTable 1
Demographic, clinical and pathological results of the entire cohort of patients, s
RECORd1 Single year evaluation
2009 2010
Gender, n. (%) Male 213 68.3% 176 64.9%
Female 99 31.7% 95 35.1%
Age, mean (SD) 64.2 11.5 62.5 12.9
BMI, median (IQR) 26.1 24.3e28.4 25.9 23.6e27.8
Symptomatologic
class, n. %
Asymptomatic 263 84.3% 225 83.0%
Local sympt. 38 12.2% 38 14.0%
Systemic sympt. 11 3.5% 8 3.0%
Indication, n. (%) Elective 256 82.1% 221 81.5%
Relative 22 7.1% 27 10.0%
Absolute 34 10.9% 23 8.5%
ECOG, n. (%) 0 198 63.5% 190 70.1%
1 89 28.5% 67 24.7%
2e3 25 8.0% 14 5.2%
Lesion site, n. (%) Polar 190 60.9% 166 61.3%
Mediorenal 122 39.1% 105 38.7%
Tumour growth
pattern, n. (%)
50% exo 230 73.7% 214 79.0%
<50% exo 75 24.0% 51 18.8%
Entirely endo 7 2.2% 6 2.2%
Clinical diameter, median (IQR) 3.0 2.0e4.0 3.0 2.0e3.7
Clinical T, n. (%) T1a 253 81.1% 229 84.5%
T1b 57 18.3% 35 12.9%
T2 2 0.6% 7 2.6%
Volume centre, n. (%) High 194 62.2% 202 74.5%
Low 118 37.8% 69 25.5%for cT1b renal masses was observed in the most recent era
(p ¼ 0.02). Intraoperative data are detailed in Table 2.
Overall, enucleoresection was the most widely adopted
technique over time (59.6% of cases), but a slightly higher
rate of SE was observed in 2012 compared to 2009
(p ¼ 0.04). Globally, OPN was adopted in almost two third
of cases (563/983; 57.2%) while the laparoscopic approach
in 30.8% of cases (302/983); since 2011, robot-assisted par-
tial nephrectomy (RAPN) has been included in the multi-
institutional database, comprehensively representing 12%
of the total cases (118/983, Table 2). Notably, we observed
a significant and persistent increase in the utilization of
RAPN in the last two years, a constant decrease in the
use of the OPN over all the period and a slight reduction
of laparoscopic NSS rate during the last two years
(Fig. 1). When stratifying the data according to the tu-
mour’s clinical stage, open and laparoscopic approaches
constantly decrease from 2008 to 2012 for the treatment
of cT1a renal tumours. In 2012 RAPN represents the
most performed treatment for cT1a (Fig. 2a). Conversely,
when considering larger tumours (cT1b), OPN constantly
decreased over the study period, laparoscopic partial ne-
phrectomy (LPN) remained approximately constant and
RAPN increased. In 2012 LPN and RAPN together repre-
sent 61.9% of interventions for cT1b tumours (Fig. 2b).
Overall, 36.3% of patients (357/983) underwent clampless
NSS and its rate constantly increased over time, from
33% in 2009 to 42.4% in 2012. When separately analysing
each approach, clampless procedures increased from 29.0%tratified by surgical era.
p
2011 2012 2009 vs 2012 2009/10 vs 2011/12
142 63.7% 106 59.9% 0.06 0.13
81 36.3% 71 40.1%
60.5 14.8 61.0 13.6 0.05 0.05
25.8 23.9e27.7 26.4 24.2e29.4 0.75 0.69
203 91.0% 167 94.4% <0.0001 0.002
18 8.1% 10 5.6%
2 0.9% 0 0.0%
170 76.2% 133 75.1% <0.0001 <0.0001
49 22.0% 38 21.5%
4 1.8% 6 3.4%
152 68.2% 139 78.5% 0.002 0.12
59 26.5% 29 16.4%
12 5.4% 9 5.1%
118 52.9% 111 62.7% 0.69 0.23
105 47.1% 66 37.3%
163 73.1% 135 76.3% 0.51 0.47
52 23.3% 36 20.3%
8 3.6% 3.4 3.4%
3.2 2.5e4.3 3.0 2.1e4.2 0.04 0.001
165 74.0% 127 71.8% 0.07 0.002
53 23.8% 46 26.0%
5 2.2% 4 2.3%
186 83.4% 134 75.7% 0.002 <0.0001
37 16.6% 43 24.3%
Table 2
Intraoperative data.
RECORd1 Single year evaluation p
2009 2010 2011 2012 2009 vs 2012 2009/10 vs 2011/12
Technique, n. % Enucleation 101 32.4% 132 48.7% 90 40.4% 74 41.8% 0.04 0.75
Enucleores/PN 211 67.6% 139 51.3% 133 59.6% 103 58.2%
Approach, n. % Open 217 69.6% 168 62.0% 110 49.3% 68 38.4% <0.0001 <0.0001
VLP 95 30.4% 103 38.0% 59 26.5% 45 25.4%
Robotic 0 0.0% 0 0.0% 54 24.2% 64 36.2%
Pedicle clamping, n % Not clamped 103 33.0% 91 33.6% 88 39.5% 75 42.4% 0.04 0.02
Clamped 209 67.0% 180 66.4% 135 60.5% 102 57.6%
Ischaemia time, median IQR 16 12e20 17 13e21 17 13e21 16 12e20 0.91 0.83
Emostatic material
used, n %
Yes 261 83.7% 250 92.3% 215 96.4% 172 97.2% <0.0001 <0.0001
No 51 16.3% 21 7.7% 8 3.6% 5 2.8%
EBL, median IQR 150 100e300 150 100e250 150 100e250 200 100e300 0.04 0.11
Operative time, median IQR 130 105e160 130 100e180 130 105e180 140 115e170 0.07 0.11
Figure 1. (a) Utilization rate of open, laparoscopic and robot-assisted par-
tial nephrectomy over time. VLP ¼ videolaparoscopic. (b) Utilization rate
of open, laparoscopic and robot-assisted partial nephrectomy for cT1a
renal tumours. (c) Utilization rate of open, laparoscopic and robot-
assisted partial nephrectomy for cT1b renal tumours.
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2011. The rate of laparoscopic PN performed without hilar
clamping increased from 42.1% in 2009 to 77.8% in 2011.
Similar results have been observed for RAPN (from 24.1%
to 35.9% in the last two years). The use of at least one hae-
mostatic agent was recorded in 91.3% of procedures (898/
983), with a significantly higher utilization in the most
recent surgical era (p < 0.001). Pathological data are re-
ported in Table 3. Globally, no statistically significant dif-
ferences among the surgical periods were found in terms
of tumour’s histological type and surgical margin status
(Table 3). Patients undergoing NSS had slightly larger path-
ological diameter in the most recent era (p ¼ 0.02) and also
the percentage of procedures for higher than pT1a RCC
renal masses significantly increased (p < 0.0001).
Discussion
The increasing utilization of non-invasive abdominal im-
aging (computed tomography, magnetic resonance imaging
and ultrasonography) during the past 20 years has led to a
significant growing number of incidentally detected small,
asymptomatic, renal masses.9,10 In this scenario, renal cell
carcinoma (RCC) has been going through a stage and size
migration.11 A not negligible amount of these asymptom-
atic SRMs will prove to be benign after definitive patholog-
ical examination.12 Considering, above all, the functional
benefits and the comparable oncological outcomes over
RN offered by NSS, partial nephrectomy has been therefore
more widely adopted among urological centres.13,14 In the
present study, we evaluated the clinical, demographic, intra-
operative and pathological data of those patients undergo-
ing PN between 2009 and 2012 in 19 Italian Institutions.
In this study, although the period considered is relatively
short (4 years), asymptomatic patients were significantly
higher in the second half of the evaluation period. Further-
more, patients of the more recent surgical era were signifi-
cantly younger and healthier. Almost 80% of the
procedures were performed in an elective setting, with a
Figure 2. Clamped and clampless of overall (a), OPN (b), VPN (c) and
RAPN procedure analysed over the period considered.
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time (7.1% in 2009 vs 21.5% in 2012, p < 0.0001).
Notably, the vast majority of patients treated with elective
PN showed an optimal performance status (ECOG ¼ 0,
p ¼ 0.002). International Guidelines recommend to perform
PN for cT1a.2 Several studies have suggested that the indi-
cations for elective PN can be safely expanded to patientswith larger (between 4 and 7 cm) or more complex renal
tumours,15e17 nevertheless with a slightly higher incidence
of postoperative complications compared to NSS performed
for cT1a tumours.18,19 According to the results of our study,
a statistically significant increase in PN utilization rates for
T1b RCC has been recorded over time (23e26% in 2011/
2012 vs 13e18% in 2009/2010, p ¼ 0.002). The utilization
rate of OPN decreased over time both for cT1a and cT1b
tumours remaining the standard and referent procedure in
centres without advanced laparoscopic and robotic exper-
tise or in case of more complex and challenging lesions
(large tumours, with hilar location or involvement of the
collecting system, Fig. 1). Conversely, LPN is a well-
established and adopted procedure in high-volume Institu-
tions with minimally invasive expertise. Robot-assisted
approach has led to a reduction in the learning curve, offer-
ing more easy and reproducible surgical steps compared to
the traditional laparoscopy, becoming a safe alternative to
OPN and LPN in the treatment of renal tumours, for both
cT1a and cT1b lesions.17,20e22 Despite the previous, histor-
ical recommendations to remove at least 1 cm of normal ap-
pearing renal parenchyma around the tumour in order to
ensure negative margins,23 the current indications for NSS
have been progressively changed. Indeed, according to
the need for preservation of as much functioning healthy
parenchyma as possible to minimize the loss of renal func-
tion,2,24 NSS has moved from maximal parenchymal resec-
tion to a minimal tissue removal. Simple enucleation (SE),
defined as the blunt enucleation of the tumour along the in-
flammatory pseudocapsule surrounding healthy paren-
chyma,25 has been used with a slightly increasing trend
over time (p ¼ 0.04, Table 2). An essential aspect of any
partial nephrectomy is to provide a complete resection of
the tumour, often in a bloodless field, within a limited
warm ischaemia time (WIT). There is a large amount of ev-
idences about the importance of reducing the WIT and the
related risk of kidney injury and CKD.26 Thompson et al.
showed that every minute of WIT was associated with a
6% increased risk of acute renal failure, 7% increased
risk of acute-onset end stage renal disease and 4% increased
risk of new-onset end stage renal disease.27 Several studies
and meta-analyses demonstrated that RAPN could be safely
performed with significantly lower WIT than LPN.28e30 In
our series, the mean WIT was always within 20 min, with
no significant differences in the surgical eras (Table 3).
Overall, clampless procedures rate significantly increased
from 33% in 2009 to 42.4% in 2012 (p ¼ 0.04) (Table
3). This result shows a higher concern of surgeons to reduce
the time of ischaemia and, whenever possible, to avoid
pedicle clamping, and has been confirmed by a sub analysis
that consider separately clampless PN rate for each
approach. In LPN and RAPN this rate constantly increased
over years, while OPN clampless rate constantly increased
in the first three years and then it decreased in 2012. A
possible explanation could be related to the case selection
towards tumours of higher complexity in the OPN group
Table 3
Pathological data.
RECORd1 Single year evaluation p
2009 2010 2011 2012 2009e2012 2009/10 vs 2011/12
Tumour nature Benign 68 21.8% 51 18.8% 36 16.1% 28 15.8% 0.50 0.63
Malignant 244 78.2% 220 81.2% 187 83.9% 149 84.2%
Pathological diameter, median IQR 3.0 2.1e4.0 3.0 2.2e3.8 3.2 2.3e4.0 3.0 2.5e4.2 0.10 0.02
Surgical margins, n. % 233 95.5% 212 96.4% 175 93.6% 141 95.3% 0.81 0.58
11 4.5% 8 3.6% 12 6.4% 8 4.7%
Pathological T pT1a 189 77.5% 166 75.5% 126 67.4% 89 59.7% <0.0001 <0.0001
pT1b 46 18.9% 31 14.1% 36 19.3% 44 29.5%
pT2 0 0.0% 4 1.8% 3 1.6% 4 2.7%
pT3 9 3.6% 19 8.6% 22 11.7% 12 8.1%
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step during PN. It depends on efficient retraction of small
vessels, appropriate clot formation, and effective occlusion
of all bleeding points with intraluminal clot or extra-
luminal compression with sutures, clips, or staples.31
Although several expected differences have been found
among all tertiary care centres, tumour bed haemostasis
has been preferably performed with interrupted and contin-
uous sutures, while the utilization of hem-o-lok/titanium
clips or argon laser represented less common techniques.
Conversely, the utilization of haemostatic agents increased
over time (p < 0.0001, Table 2), with predominantly use of
tissue sealants agent, particularly during LPN and RAPN
although their efficacy to reduce the risk of postoperative
bleeding has not been proved yet.32 When performing
NSS for RCC, the complete removal of the tumour and
the avoidance of positive surgical margins (PSMs) is of
paramount importance, to reach optimal long-term onco-
logical control. In the current literature, the overall inci-
dence of PSMs after nephron-sparing surgery, when
performed electively is quite low, ranging from 0% to
7%33 and according to the surgical approach, the rate of
PSMs is generally comparable between the different ap-
proaches.33 In our series, the overall PSMs rate is compara-
ble to those reported in literature, with no significant
differences in the surgical eras (Table 3). It must be noted
that the findings reported in the present paper should be
considered in the context of the study design. Our analysis
represents only a limited investigation on our prospective
multi-Institutional evaluation over a 4-year period. Clearly,
data are not reflective of all urological centres and should
not be generalized, thus not being applicable to other Cen-
tres with lowest surgical volume. The study lacks of any
comparative intent between different PN approaches; anal-
ysis of surgical or medical complications, costs are beyond
the scope of the dataset which has the main aim in
describing the actual features of nephron-sparing surgery
in Italy, with particular attention to significant trends that
could be recorded during each year investigated and,
though in absence of any comparison with RN, in support-
ing the role of PN as an established standard of care for
RCC.Conclusion
Nephron-sparing surgery still remains the gold standard
treatment for clinically localized RCC, whenever techni-
cally feasible. The utilization rate of NSS in high-volume
Italian Centres is increasing over time, even in elective
and more complex cases, with optimal results and safety
profile. Robot-assisted partial nephrectomy is being much
more adopted in the recent years compared to traditional
laparoscopy. The rate of clampless procedures, regardless
of the surgical approach, as well as the utilization of hae-
mostatic agents at the end of the procedure, increased
over time.
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